Latest Davita Healthcare Partners Inc (DVA) Headlines
3 Health Care Companies Warren Buffett Loves
Todd Campbell, The Motley Fool - Motley Fool - Thu Mar 13, 5:30PM CDT
Warren Buffett believes in buying companies for the long haul, so Berkshire Hathaway's positions are usually concentrated bets on businesses that are easy to understand. While Buffett's team, which includes Ted Weschler, has found more companies...
'Mad Money' Lightning Round: No Fan of Lionsgate
at The Street - Thu Mar 13, 5:00AM CDT
Cramer is cautious on Cara Therapeutics but thinks DaVita is a terrific health care play.
Jim Cramer's 'Mad Money' Recap: Lost in the Rotation
at The Street - Wed Mar 12, 7:07PM CDT
The market's gyrations may seem maddening to those with longer-term views so those investors need to stay diversified, Cramer says.
DaVita Google+ Hangout on Air to Address Worldwide Health Concern
PR Newswire - Tue Mar 11, 5:14AM CDT
DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, will host a Google+ Hangout on Air dedicated to global kidney disease awareness on World Kidney Day.
Buffett Can't Get Enough of This Stock
Keith Speights, The Motley Fool - Motley Fool - Sun Mar 09, 7:00AM CDT
Warren Buffett's Berkshire Hathaway began scooping up shares of DaVita Healthcare Partners , a dialysis provider, back in 2011. The trend continued last week: SEC filings revealed that Berkshire purchased another 1.15 million shares. This...
Warren Buffett's 10 Favorite Stocks
at The Street - Fri Mar 07, 12:27PM CST
These are Berkshire Hathaway's 10 largest holdings.
3 Reasons Buffett Whiz Ted Weschler Likes DaVita HealthCare Partners
Todd Campbell, The Motley Fool - Motley Fool - Wed Mar 05, 5:30PM CST
Warren Buffett has a team helping him find compelling long-term investments and one of those people is Ted Weschler; the person behind Berkshire's nearly 18% ownership stake in dialysis and health care provider company DaVita . Weschler's...
This $23 Billion Long-Term Winner Has Been Buying Health Care and Lumber
Selena Maranjian, The Motley Fool - Motley Fool - Wed Mar 05, 4:17PM CST
The latest 13F season is commencing, when many money managers issue required reports on their holdings. It can be worthwhile to pay attention, as you might get an investment idea or two by seeing what some major investors have been buying and...
Gentiva Posts Q4 Loss, Guides 2014 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 9:00AM CST
Gentiva Health Services, Inc. reported fourth-quarter 2013 adjusted loss of 14 cents per share
FORTUNE Magazine Names DaVita Among Most Admired Companies for Ninth Consecutive Year
PR Newswire - Wed Mar 05, 3:12AM CST
DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, has been recognized as one of FORTUNE® Magazine's Most Admired Companies in 2014. This marks the fifth consecutive year DaVita has been ranked no. 1 in innovation for health care facilities and the ninth consecutive year DaVita has earned the honor as one of the World's Most Admired Companies by FORTUNE.
National Kidney Month: DaVita Encourages Those at Risk for Kidney Disease to Make New Resolution
PR Newswire - Mon Mar 03, 3:12AM CST
DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is encouraging people who are at risk for kidney disease to make a new resolution to learn and understand their risk during National Kidney Month.
Aethlon Medical® Announces Agreement with DaVita Clinical Research®
PR Newswire - Wed Feb 26, 7:03AM CST
Aethlon Medical, Inc. (OTCQX:AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that that it has reached an agreement in principle with DaVita Clinical Research® (DCR) to provide clinical management services that will support forthcoming studies of the Aethlon Hemopurifier®. The Hemopurifier® is a first-in-class therapeutic device that targets the rapid elimination of circulating viruses and tumor-secreted exosomes that suppress the immune system of cancer patients.
Everyone Loves Warren Buffett, But Should We?
at The Street - Tue Feb 25, 9:03AM CST
Investing the Warren Buffett way won't give you above-market returns in a market that's rising.
DaVita Set to Possibly Pullback After Yesterday's Rally of 2.07%
Comtex SmarTrend(R) - Mon Feb 24, 5:38PM CST
VA) traded in a range yesterday that spanned from a low of $66.04 to a high of $68.83. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $67.00 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
2 Critical Things to Remember When You See What Warren Buffett Buys and Sells
Patrick Morris, The Motley Fool - Motley Fool - Sun Feb 23, 10:00AM CST
A month and a half after each quarter ends, every major investor has to reveal what stocks they bought and sold. While there are always things to learn and surprises to be had, investors must always keep two things in mind when reviewing what is...
Is Buffett Abandoning Health-Care Stocks?
David Williamson, The Motley Fool - Motley Fool - Sat Feb 22, 12:05PM CST
Warren Buffett's Berkshire Hathaway just disclosed in a fourth-quarter filing that it has liquidated its position in big pharma stock GlaxoSmithKline . Does that mean Buffett is abandoning the health-care industry? Should investors follow the...
Chemed Corp. (CHE) in Focus: Stock Moves 10.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:18AM CST
Chemed Corp. (CHE) was a big mover last session, as the company saw its shares rise by over 10% on the day.
DaVita Urges African-Americans to Learn About Their Risk for Kidney Disease During Black History Month
PR Newswire - Tue Feb 18, 3:18AM CST
DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, is encouraging African-Americans to learn about their risk for kidney disease during Black History Month.
Here's What Warren Buffett Has Been Buying and Selling
Selena Maranjian, The Motley Fool - Motley Fool - Mon Feb 17, 12:30PM CST
Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright light on smart stock picks. Today let's look at investing giant Warren Buffett. His Berkshire Hathaway ...